The Urology Devices Market is estimated to reach USD 46.4 billion by 2026, up from USD 38.0 billion in 2021, at a CAGR of 4.1 percent, according to a new MarketsandMarketsTM analysis. The rising incidence and prevalence of urological illnesses, as well as the increasing number of hospitals and investments in endoscopy and laparoscopy facilities, are the key forces driving the growth of the urology devices market.
The market for urological devices is separated into two parts: instruments and consumables, and accessories. In 2020, the instruments category had the biggest share. This can be attributed to key players developing new and improved urological equipment, as well as a rising preference for less intrusive procedures.
The urology devices market is segmented by application, including renal diseases, urological cancer and BPH, pelvic organ prolapse, and others. The renal illnesses category had the largest market share in 2020. This is due to an aging population and an increase in the prevalence of kidney diseases.
Based on end users, the urology devices market is segmented into hospitals, ASCs and clinics, dialysis facilities, and home care settings. In 2020, hospitals, ASCs, and clinics held the most market share. The rising use of urology devices and consumables to serve a large patient population is the key driver of this segment’s growth.
